A local site principal investigator for the MVP program, Hung also is principal investigator of an MVP grant exploring the genetics of kidney disease and hypertension
Mol Med (2019) 26:6
The semaglutide case exemplifies how the patent system has been turned into a key instrument of the pharmaceutical industrys financialized business model
Thats why any patient being treated with compounded GLP-1s can review a Certificate of Analysis (CoA) detailing the testing results associated with their medication
is one of the former Editors-in-Chief of CKJ and has received grants from Sanofi and consultancy or speaker fees or travel support from Adviccene, Alexion, Astellas, AstraZeneca, Amicus, Amgen, Boehringer Ingelheim, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Menarini, Mundipharma, Kyowa Kirin, Lilly, Freeline, Idorsia, Chiesi, Otsuka, Novo Nordisk, Sysmex, Vifor Fresenius Medical Care Renal Pharma and Spafarma and is Director of the Catedra UAM-AstraZeneca of chronic kidney disease and electrolytes